Sectoral Asset Management Inc Rallybio Corp Transaction History

Sectoral Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$4.31 - $8.89 $758,460 - $1.56 Million	-175,977 Reduced 31.88%	375,960 $2.13 Million
Q1 2023 May 12, 2023	SELL	$4.37 - $8.75 $296,958 - $594,597	-67,954 Reduced 10.96%	551,937 $3.15 Million
Q4 2022 Feb 10, 2023	BUY	$4.67 - $14.86 $1.81 Million - $5.74 Million	386,510 Added 165.61%	619,891 $4.07 Million
Q3 2022 Nov 10, 2022	SELL	$7.54 - $14.56 $843,997 - $1.63 Million	-111,936 Reduced 32.42%	233,381 $3.38 Million
Q2 2022 Aug 15, 2022	SELL	$6.26 - $13.65 $248,847 - $542,614	-39,752 Reduced 10.32%	345,317 $2.61 Million
Q1 2022 May 10, 2022	BUY	$6.91 - $15.04 $579,355 - $1.26 Million	83,843 Added 27.83%	385,069 $2.69 Million
Q4 2021 Feb 11, 2022	SELL	$9.3 - $19.91 $2.1 Million - $4.5 Million	-225,910 Reduced 42.86%	301,226 $2.87 Million
Q3 2021 Nov 15, 2021	BUY	$10.83 - $23.4 $5.71 Million - $12.3 Million	527,136 New	527,136 $9.27 Million

32.9M

Ticker RLYB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,132,000
Market Cap $24.1M
Description
Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.